A fingerprint pair analysis of hERG inhibition data

Chemistry Central Journal

Volumn 7, Issue 1, 2013, Pages

  Springer, Clayton ^a   Sokolnicki, Katherine L ^a  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Cliff pairs; Extended connectivity fingerprints (ECFP); Fingerprint pairs; hERG; Hydroxyl; Molecular matched pairs; Molecular pair

Indexed keywords

EID: 84885734081     PISSN: None     EISSN: 1752153X     Source Type: Journal    
DOI: 10.1186/1752-153X-7-167     Document Type: Article

References (26)

1. Sanguinetti MC, Jiang C, Curran ME, Keating MT. A mechanistic link between an inherited and an acquired cardiac arrthytmia: HERG encodes the IKr potassium channel. Cell 1995, 81(2):299-307. 10.1016/0092-8674(95)90340-2, 7736582.
2. Redfern WS, Wakefield ID, Prior H, Pollard CE, Hammond TG, Valentin JP. Safety pharmacology - a progressive approach. Fundam Clin Pharmacol 2002, 16(3):161-173. 10.1046/j.1472-8206.2002.00098.x, 12165064.
3. Roy M. HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine. Circulation 1996, 94(4):817. 10.1161/01.CIR.94.4.817, 8772706.
4. Whitebread S, Hamon J, Bojanic D, Urban L. Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development. Drug Discov today 2005, 10(21):1421-1433. 10.1016/S1359-6446(05)03632-9, 16243262.
5. Duda RO, Hart PE, Stork DG. Pattern classification 2000, Hoboken NJ: Wiley-Interscience.
6. Hastie T, Tibshirani R, Friedman J. The Elements of Statistical Learning: data mining, inference, and prediction 2009, Berlin: Springer-Verlag, 2.
7. Keserü GM. Prediction of hERG potassium channel affinity by traditional and hologram QSAR methods. Bioorg Med Chem Lett 2003, 13:2773-2775. 10.1016/S0960-894X(03)00492-X, 12873512.
8. Seierstad M, Agrafiotis D. A QSAR model of hERG binding using a large, diverse, and internally consistent training Set. Chem Biol Drug Des 2006, 67(4):284-296. 10.1111/j.1747-0285.2006.00379.x, 16629826.
9. Maggiora GM. On outliers and activity cliffs - Why QSAR often disappoints. J Chem Inf Model 2006, 46(4):1535. 10.1021/ci060117s, 16859285.
10. Guha R, Van Drie JH. Structure-activity landscape index: identifying and quantifying activity cliffs. J Chem Inf Model 2008, 48(3):646-658. 10.1021/ci7004093, 18303878.
11. Van Drie JH, Guha R. Assessing how well a modeling protocol captures a structure activity landscape. J Chem Inf Model 2008, 48(8):1716-1728. 10.1021/ci8001414, 18686944.
12. Sheridan RP, Hunt P, Culberson JC. Molecular transformations as a way of finding and exploiting consistent local QSAR. J Chem Inf Model 2006, 46(1):180-192. 10.1021/ci0503208, 16426054.
13. Jamieson C, Moir EM, Rankovic Z, Wishart G. Medicinal chemistry of hERG optimizations: highlights and hang-Ups. J Med Chem 2006, 49(17):5029-5046. 10.1021/jm060379l, 16913693.
14. Leach AG, Jones HD, Cosgrove DA, Kenny PW, Ruston L, MacFaul P, Wood JM, Colclough N, Law B. Matched molecular pairs as a guide in the optimization of pharmaceutical properties; a study of aqueous solubility, plasma protein binding and oral exposure. J Med Chem 2006, 49(23):6672-6682. 10.1021/jm0605233, 17154498.
15. Papadatos G, Alkarouri M, Gillet VJ, Willett P, Kadirkamanathan V, Luscombe CN, Bravi G, Richmond NJ, Pickett SD, Hussain J, Pritchard JM, Cooper AWJ, Macdonald SJF. Lead optimization using matched molecular pairs: inclusion of contextual information for enhanced prediction of hERG inhibition, solubility, and lipophilicity. J Chem Inf Model 2010, 50(10):1872-1886. 10.1021/ci100258p, 20873842.
16. Grimme S. Do special noncovalent π-π stacking interactions really exist?. Angew Chem 2008, 47(18):3430-3434.
17. Perrin CL, Fabian MA, Rivero I. Basicities of cycloalkylamines: baeyer strain theory revisited. Tetrahedron 2012, 55:5773-5780.
18. Wildman SA, Crippen GM. Prediction of physicochemical parameters by atomic contributions. J Chem Inf Comput Sci 1999, 39(5):868-873.
19. Ertl P. Fast calculation of molecular polar surface area as a Sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem 2000, 43:3714-3717. 10.1021/jm000942e, 11020286.
20. Lipkowitz KB, Boyd DB, Hall LH, Kier LB. " The molecular connectivity Chi indexes and kappa shape indexes in structure property modeling" in Reviews. Comput Chem 1991, 2:367-422.
21. Pearlman RS, Smith KM. Novel software tools for chemical diversity. 3D QSAR in drug design, 2 2002, Dordrecht: Kluwer Academic Publishers, Kubinyi H, Folkers G, Martin YC.
22. Finlayson K, Turnbull L, January CT, Sharkey J, Kelly JS. [3H]Dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen. Eur J Pharmacol 2001, 430(1):147-148. 10.1016/S0014-2999(01)01362-0, 11698075.
23. Rogers D, Hahn M. Extended-connectivity fingerprints. J Chem Inf Model 2010, 50(5):742-754. 10.1021/ci100050t, 20426451.
24. Glick M. Comparison of 2D-based descriptors for virtual screening using multiple bioactive reference structures. Chemogenomics: an emerging strategy for rapid target and drug discovery 2006, 133-156.
25. Hussain J, Rea C. Computationally efficient algorithm to identify matched molecular pairs (MMPs) in large data sets. J Chem Inf Model 2010, 50(3):339-348. 10.1021/ci900450m, 20121045.
26. Chemical Computing Group Inc MOE (the molecular operating environment) version 2009.10 2012, Montreal, Canada: Chemical Computing Group, Chemical Computing Group Inc.